Showing results (31-40 of 109) with videos related to
Sort By:
Pageof 11
ACS Chemical Neuroscience|July 2, 2021
COVID-19 as a Trigger of Brain AutoimmunityMayuri Gupta, Donald F WeaverBiophysical Chemistry|November 22, 2021
Axonal plasma membrane-mediated toxicity of cholesterol in Alzheimer's disease: A microsecond molecular dynamics studyMayuri Gupta, Donald F WeaverJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 15, 2018
Topically applied linoleic/linolenic acid for chronic migraineClarissa Santos, Donald F WeaverInternational Immunopharmacology|August 18, 2022
Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's diseaseZhiyu Wang, Donald F WeaverNeurosci|January 21, 2026
β-Alanine Is an Unexploited Neurotransmitter in the Pathogenesis and Treatment of Alzheimer's DiseaseCindy M Wozniczka, Donald F WeaverThe Journal of Pharmacy and Pharmacology|December 31, 2010
Exploring neurotherapeutic space: how many neurological drugs exist (or could exist)?Donald F Weaver, Colin A WeaverNeuroscience Letters|April 7, 2007
Anaesthetic binding sites for etomidate and propofol on a GABAA receptor modelValérie Campagna-Slater, Donald F WeaverThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 26, 2008
Deducing the bioactive face of hydantoin anticonvulsant drugs using NMR spectroscopyKathryn E Tiedje, Donald F WeaverJournal of Computer-Aided Molecular Design|December 15, 2004
Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitorsJeffrey J Sutherland, Donald F WeaverEpilepsia|May 8, 2013
Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s)Donald F Weaver, Bernd Pohlmann-EdenPageof 11